Transcat (TRNS) stake updated in Conestoga Capital Advisors Schedule 13G/A

Rhea-AI Filing Summary

Conestoga Capital Advisors filed Amendment No. 5 to a Schedule 13G reporting its beneficial ownership of Transcat Inc. common stock. Conestoga Capital Advisors reports beneficial ownership of 1,013,365 shares, representing 10.86% of the outstanding common stock, with sole voting power over 943,437 shares and sole dispositive power over 1,013,365 shares. CONESTOGA FUNDS reports beneficial ownership of 626,699 shares, or 6.72% of the class, with sole voting and dispositive power over those shares. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Transcat Inc.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 5)

TRANSCAT INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

893529107

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 893529107

1

Names of Reporting Persons

Conestoga Capital Advisors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 943,437.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,013,365.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,013,365.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.86 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 893529107

1

Names of Reporting Persons

CONESTOGA FUNDS

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 626,699.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 626,699.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

626,699.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.72 %

12

Type of Reporting Person (See Instructions)

IV

SCHEDULE 13G

Item 1.
(a)	Name of issuer: TRANSCAT INC
(b)	Address of issuer's principal executive offices: 35 Vantage Point Drive, Rochester, NEW YORK 14624
Item 2.
(a)	Name of person filing: Conestoga Capital Advisors CONESTOGA FUNDS
(b)	Address or principal business office or, if none, residence: 550 E. SWEDESFORD ROAD SUITE 120 WAYNE, Pennsylvania 19087
(c)	Citizenship: Conestoga Capital Advisors - DELAWARE CONESTOGA FUNDS - DELAWARE
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 893529107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Conestoga Capital Advisors - 1,013,365 CONESTOGA FUNDS - 626,699
(b)	Percent of class: 10.86 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Conestoga Capital Advisors - 943,437 CONESTOGA FUNDS - 626,699
	(ii) Shared power to vote or to direct the vote: Conestoga Capital Advisors - 0 CONESTOGA FUNDS - 0
	(iii) Sole power to dispose or to direct the disposition of: Conestoga Capital Advisors - 1,013,365 CONESTOGA FUNDS - 626,699
	(iv) Shared power to dispose or to direct the disposition of: Conestoga Capital Advisors - 0 CONESTOGA FUNDS - 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Conestoga Capital Advisors

Signature:	Duane R. D'Orazio
Name/Title:	Managing Partner
Date:	01/09/2026

CONESTOGA FUNDS

Signature:	Duane R. D'Orazio
Name/Title:	Managing Partnerr
Date:	01/09/2026

FAQ

What does the Schedule 13G/A filing disclose about Conestoga's stake in Transcat (TRNS)?

The filing shows that Conestoga Capital Advisors beneficially owns 1,013,365 shares of Transcat Inc. common stock, representing 10.86% of the outstanding class.

How many Transcat (TRNS) shares are reported by CONESTOGA FUNDS?

CONESTOGA FUNDS reports beneficial ownership of 626,699 Transcat Inc. common shares, representing 6.72% of the class, with sole voting and dispositive power over those shares.

What voting and dispositive powers does Conestoga Capital Advisors report over Transcat (TRNS) shares?

Conestoga Capital Advisors reports sole voting power over 943,437 shares and sole dispositive power over 1,013,365 shares of Transcat Inc. common stock, with no shared voting or dispositive power.

Why was this Schedule 13G/A Amendment No. 5 filed for Transcat (TRNS)?

The amendment reflects updated beneficial ownership information for Conestoga Capital Advisors and CONESTOGA FUNDS in Transcat Inc. as of the 12/31/2025 event date.

Is Conestoga seeking to influence control of Transcat (TRNS) through this ownership?

The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing the control of Transcat Inc.

What type of reporting person is Conestoga Capital Advisors in this Transcat (TRNS) filing?

Conestoga Capital Advisors is identified as an investment adviser (IA) organized in Delaware, filing jointly with CONESTOGA FUNDS, which is classified as IV.